文献速递胰腺与胆道疾病消化内镜消化道肿瘤与早癌

二代测序指导不明原因主胰管扩张患者的管理改变:多中心队列研究

Changes to management influenced by next-generation sequencing of pancreatic duct aspirates among patients with main pancreatic duct dilatation of unclear etiology: a multicenter cohort study.
PubMed 文献 · Gastrointest Endosc · 2025-11-20

这项多中心回顾性队列纳入62例不明原因主胰管扩张(≥6 mm)患者,评估胰管抽吸物二代测序(NGS)对临床管理的影响。NGS在64.5%患者中检出突变,总体27.4%患者的管理因此改变,包括11例新增手术和6例避免手术;EUS-FNA与ERCP不良事件率无差异。

要点

  • 不明原因主胰管扩张患者中,NGS检出突变者占64.5%。
  • NGS使27.4%患者的管理发生改变,包括新增或避免手术。
  • EUS-FNA与ERCP抽吸的不良事件率均为8.1%,无差异。

核心结论

  • 对不明原因主胰管扩张患者,胰管抽吸物NGS安全,并使超过四分之一患者的手术管理发生改变。

研究设计与样本

  • 多中心回顾性队列研究,纳入2个学术机构中主胰管扩张≥6 mm且病因不明的62例患者。

主要发现

  • NGS突变见于40例(64.5%)患者,提示肿瘤性病因。
  • NGS提示肿瘤性病因使11例既往无手术指征患者接受手术治疗。
  • 6例主胰管≥10 mm患者NGS归因于慢性胰腺炎,虽既往推荐手术但手术被推迟。
  • 总体管理改变17例(27.4%)。
  • EUS-FNA与ERCP抽吸的不良事件率均为8.1%,两种技术间无差异。

临床怎么用

  • 对不明原因主胰管扩张患者,可考虑行胰管抽吸联合NGS作为辅助诊断手段以指导手术决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Main pancreatic duct (MPD) dilatation of unclear etiology presents a diagnostic challenge because the management of neoplastic and non-neoplastic causes differs significantly. We aimed to assess the clinical utility of next-generation sequencing (NGS) in the management of MPD dilatation. METHODS: We retrospectively identified patients with dilated MPD (≥6 mm) of unclear etiology who underwent NGS at 2 academic institutions. The primary outcome was any change to management influenced by NGS compared with previous standard of practice. Adverse event rates of EUS fine-needle aspiration and ERCP were compared. RESULTS: A total of 62 patients with dilated MPD were identified; they had a mean age of 71.5 ± 12.1 years, and 53.2% were men. The majority had chronic pancreatitis (54.8%). The average MPD diameter was 8.6 ± 2.3 mm. MPD aspiration was performed by EUS fine-needle aspiration in 33 patients (53.2%) and ERCP in 29 patients (46.8%). The adverse event rate was 8.1%, with no difference between aspiration techniques observed. NGS mutations were present in 40 (64.5%) patients. The identification of mutations suggesting a neoplastic cause of MPD dilatation resulted in surgical management for 11 patients with no previous indication. In 6 cases with MPD ≥10 mm, dilatation was attributed to chronic pancreatitis and surgery was deferred despite previous practice of recommending surgery. Overall, management was changed in 17 (27.4%) patients. CONCLUSIONS: In a multicenter cohort of patients with MPD dilatation, NGS of MPD aspirates was safe and changed surgical management for more than one-quarter of patients. Providers should consider MPD sampling with NGS as an ancillary diagnostic modality for patients presenting with MPD dilatation of unclear etiology.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Jones AR, Kannan A, Ley D, et al. Changes to management influenced by next-generation sequencing of pancreatic duct aspirates among patients with main pancreatic duct dilatation of unclear etiology: a multicenter cohort study. Gastrointest Endosc. 2025. PMID: 41274358. doi:10.1016/j.gie.2025.11.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。